[ad_1]
A panel of health experts advising the U.S. government on vaccines has expressed preliminary support for administering Covid-19 boosters to immunocompromised people, but said it was waiting for regulatory action before making a formal recommendation.
A working group of the Advisory Committee on Immunization Practices also approved the continued use of J & J’s vaccine on Thursday, despite a recent warning about a low risk of a rare neurological disorder in people who do get vaccinated.
The ACIP panel, which advises the United States Centers for Disease Control and Prevention, develops recommendations for general vaccine use in the United States. The committee is made up of experts in infectious diseases, immunology and public health.
Its review of recalls came as evidence grows that Covid-19 vaccines are less effective in people with weakened immune systems than the rest of the general population, increasing the risk of infection and serious illness.
About 2.7% of adults in the United States are considered immunocompromised, according to the CDC, including transplant recipients, some cancer survivors and people living with HIV. This makes them less sensitive to vaccines, which require stimulation of the immune system to provide protection.
[ad_2]
Source link